13F filer · CIK 1431431
CLARUS VENTURES, LLC
CAMBRIDGE, MA · filing since Q4 2013 · last filing Nov 14, 2025
Reported value
$425.5M
+$144.3M vs prior
Positions
10
New / sold out
2 / 0
Added / reduced
1 / 0
Turnover
0.0%
buys $55.6M · sells $0
Top-10 weight
100.0%
Biggest buys vs Q2 2018
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | Gritstone Oncology Inc | +2,567,445 | – | +$36.6M |
| New | Entasis Therapeutics Holdings Inc | +1,623,405 | – | +$17.7M |
| Added | Nanostring Technologies Inc. | +76,585 | +1.9% | +$1.4M |
Biggest sells vs Q2 2018
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2018
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | AvroBio Inc.COM | 2,962,325 | $153.7M | 36.11% |
| 2 | Nanostring Technologies Inc.COM | 4,036,025 | $72.0M | 16.91% |
| 3 | Sientra Inc.COM | 2,730,765 | $65.2M | 15.33% |
| 4 | Forty Seven IncCOM | 3,816,951 | $56.9M | 13.38% |
| 5 | Gritstone Oncology IncCOM | 2,567,445 | $36.6M | 8.59% |
| 6 | Entasis Therapeutics Holdings IncCOM | 1,623,405 | $17.7M | 4.15% |
| 7 | Restoration Robotics Inc.COM | 3,569,986 | $10.4M | 2.43% |
| 8 | VBI Vaccines Inc.COM | 2,691,042 | $6.5M | 1.53% |
| 9 | ESSA Pharma Inc.COM | 1,668,560 | $5.0M | 1.18% |
| 10 | Catabasis Pharmaceuticals Inc.COM | 2,008,192 | $1.6M | 0.38% |